| http://www.w3.org/ns/prov#value | - Below is a press release from the company explaining more:GW Pharmaceuticals plc (Nasdaq: GWPH, AIM: GWP, ???GW???) a biopharmaceutical company focused on discovering, developing and commercializing novel therapeutics from its proprietary cannabinoid product platform, announced today it has commenced a Phase 1b/2a clinical trial for the treatment of Recurrent Glioblastoma Multiforme (GBM).Glioma d
|
